Wreggett K A, De Léan A
Mol Pharmacol. 1984 Sep;26(2):214-27.
Agonists and antagonists interact with the pituitary D2-dopamine receptor in a complex fashion that has been accounted for by proposing that the receptor exists in two interconvertible affinity states [De Lean et al., Mol. Pharmacol. 22:290-297 (1982)]. These two states appear to be modulated by guanine nucleotides such that the state existing in the presence of excess guanine nucleotide has low affinity for agonists and high affinity for antagonists. These observations, together with several lines of evidence from other laboratories, have suggested the interaction of the receptor with a guanine nucleotide-binding protein and a model describing the reversible interaction of the receptor (R) with an additional membrane component (X) was studied [De Lean et al., J. Biol. Chem. 255:7108-7117 (1980)]. Several properties of this ternary complex model are presented and discussed in terms of the interpretation of the analysis of simulated binding data using the mass-action model. Computer modeling of experimental binding data obtained from membrane homogenates of bovine anterior pituitary glands indicated that a ternary complex model will fit only under conditions where, in the absence of any ligand, there is a tight interaction or "precoupling" of R with X, with the latter being in stoichiometrically limiting amounts; antagonists and guanine nucleotides would tend to destabilize this interaction, whereas agonists would serve to stabilize the coupled form. These results, for a receptor system that inhibits adenylate cyclase activity, are notably different from those observed for the beta-adrenergic receptor, which stimulates the enzyme and may be a reflection of differences in the molecular mechanisms of the interaction of the two receptor systems with their ligands and their effector. Some features of the model are not compatible with the experimental data and have indicated the need to consider extensions of the model, in light of recent advancements in our understanding of these regulatory components. Our results stress the importance of verifying the properties of proposed models and of cautiously testing these proposed models by their direct application to experimental data.
激动剂和拮抗剂以复杂的方式与垂体D2 - 多巴胺受体相互作用,这种相互作用可以通过提出受体存在两种可相互转换的亲和状态来解释[德莱安等人,《分子药理学》22:290 - 297(1982)]。这两种状态似乎受鸟嘌呤核苷酸调节,使得在过量鸟嘌呤核苷酸存在下存在的状态对激动剂具有低亲和力,而对拮抗剂具有高亲和力。这些观察结果,连同其他实验室的几条证据,提示了受体与鸟嘌呤核苷酸结合蛋白的相互作用,并研究了一个描述受体(R)与另一种膜成分(X)可逆相互作用的模型[德莱安等人,《生物化学杂志》255:7108 - 7117(1980)]。本文根据使用质量作用模型对模拟结合数据的分析解释,介绍并讨论了该三元复合物模型的几个特性。从牛垂体前叶膜匀浆获得的实验结合数据的计算机模拟表明,三元复合物模型仅在以下条件下适用:在没有任何配体的情况下,R与X存在紧密相互作用或“预偶联”,且X的化学计量数量有限;拮抗剂和鸟嘌呤核苷酸倾向于破坏这种相互作用,而激动剂则有助于稳定偶联形式。对于抑制腺苷酸环化酶活性的受体系统,这些结果与β - 肾上腺素能受体观察到的结果明显不同,β - 肾上腺素能受体刺激该酶,这可能反映了两种受体系统与其配体和效应器相互作用的分子机制的差异。该模型的一些特征与实验数据不相符,这表明鉴于我们对这些调节成分理解的最新进展,需要考虑对模型进行扩展。我们的结果强调了验证所提出模型的特性以及通过直接将这些模型应用于实验数据来谨慎测试这些模型的重要性。